Glucagon-like receptor-1 agonists and impotence: A meta-analysis

Figure 1  The association between erectile dysfunction and glucagon-like peptide receptors-1 agonist (the PRISMA chart).

Figure 2 Glucagon-like peptide receptors-1 agonists effect on impotence and pituitary-testicular axis. A: Glucagon-like peptide receptors-1 agonists (GLP-1 agonists) effect on impotence; B: GLP-1 agonists’ effect on impotence (no heterogeneity); C: Total testosterone in GLP-1 agonists and controls; D: Free testosterone in GLP-1 agonists and controls; E: Sex hormone binding globulin in GLP-1 agonists and controls; F: Luteinizing hormone in GLP-1 agonists and controls; G: Follicular-stimulating hormone in GLP-1 agonists and controls.